Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.
van der Sluis IM, de Groot-Kruseman H, Te Loo M, Tissing WJE, van den Bos C, Kaspers GJL, Bierings M, Kollen WJW, König T, Pichlmeier U, Kühnel HJ, Pieters R. van der Sluis IM, et al. Among authors: te loo m. Pediatr Blood Cancer. 2018 Aug;65(8):e27083. doi: 10.1002/pbc.27083. Epub 2018 May 4. Pediatr Blood Cancer. 2018. PMID: 29727043 Clinical Trial.
Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients.
Sassen SD, Mathôt RA, Pieters R, Kloos RQ, de Haas V, Kaspers GJ, van den Bos C, Tissing WJ, Te Loo M, Bierings MB, Kollen WJ, Zwaan CM, van der Sluis IM. Sassen SD, et al. Among authors: te loo m. Haematologica. 2017 Mar;102(3):552-561. doi: 10.3324/haematol.2016.149195. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28250007 Free PMC article.
Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01.
De Moerloose B, Reedijk A, de Bock GH, Lammens T, de Haas V, Denys B, Dedeken L, van den Heuvel-Eibrink MM, Te Loo M, Uyttebroeck A, Van Damme A, Van der Werff-Ten Bosch J, Zsiros J, Kaspers G, de Bont E. De Moerloose B, et al. Among authors: te loo m. Pediatr Blood Cancer. 2019 May;66(5):e27605. doi: 10.1002/pbc.27605. Epub 2019 Jan 8. Pediatr Blood Cancer. 2019. PMID: 30623572
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.
Hagleitner MM, Coenen MJ, Patino-Garcia A, de Bont ES, Gonzalez-Neira A, Vos HI, van Leeuwen FN, Gelderblom H, Hoogerbrugge PM, Guchelaar HJ, Te Loo MW. Hagleitner MM, et al. Among authors: te loo mw. PLoS One. 2014 Dec 31;9(12):e115869. doi: 10.1371/journal.pone.0115869. eCollection 2014. PLoS One. 2014. PMID: 25551397 Free PMC article.
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).
Driessen CM, Ham JC, Te Loo M, van Meerten E, van Lamoen M, Hakobjan MH, Takes RP, van der Graaf WT, Kaanders JH, Coenen MJH, van Herpen CM. Driessen CM, et al. Among authors: te loo m. Cancers (Basel). 2019 Apr 17;11(4):551. doi: 10.3390/cancers11040551. Cancers (Basel). 2019. PMID: 30999660 Free PMC article.
Anticardiolipin antibodies in D+ hemolytic uremic syndrome.
te Loo M, van der Velden T, Onland W, van den Heuvel L, Monnens L. te Loo M, et al. Pediatr Nephrol. 2002 Dec;17(12):1042-6. doi: 10.1007/s00467-002-0965-4. Epub 2002 Nov 1. Pediatr Nephrol. 2002. PMID: 12478355 Clinical Trial.
17 results